TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time spent on radial artery cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Production of anti-S1-RBD IgG antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Duration of Magnesium Sulfate Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barthell Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional Ambulatation Categories
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Blood Pressure Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median Global Progression-Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in the number of monthly migraine headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete semen analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Laboratory Abnormalities from Clinical Laboratory Values (Hematology and Chemistry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: individual performance of non-technical skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline in Hammersmith Functional Motor Scale Expanded (HFMSE) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long term effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute complication (< 30 days)
Endpoint domain: Adverse events/effects
Primary endpoint: Chronic complication (> 30 days)
Endpoint domain: Adverse events/effects
Primary endpoint: Baseline balance and functional mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort measure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RNA biomarkers in blood & cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein biomarkers in blood & cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolite biomarkers in blood & cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to HPV self-sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to conventional screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of symptom distress caseness (distress prevalence)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with suboptimal weight control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in total score of health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronary Artery Disease Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MSK ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: sitting Functional and Lateral Reach Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in liver size by palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cardiac function as assessed by ejection fraction on echocardiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 18-month progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Ischemic Stroke and TIA
Endpoint domain: Adverse events/effects
Primary endpoint: Major adverse bleeding event
Endpoint domain: Adverse events/effects
Primary endpoint: Health of mother using CGM to monitor blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health of baby using delivery and post delivery well baby assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported wrist and hand evaluation (PRWHE)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of life of older adults
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Enrollment and retention percentages
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Engagement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mHealth App Usability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: State trait anxiety inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of patients that maintain MRD negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants with mitral regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with adverse event of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Health Questionnaire - 9
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Reporting Freedom from Documented Atrial Tachyarrhythmia Episodes
Endpoint domain: Adverse events/effects
Primary endpoint: baby's weight gain/decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax in postprandial plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUC0-t in postprandial plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUC0-∞ in postprandial plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of subjects who discontinued treatment prematurely
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients with clinically significant abnormal laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of perinatal depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ctDNA gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumor-specific proteins expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who completed Advance Directives
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: horizontal alveolar width measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of epileptic seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Seroconversion rates of the varicella antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates of anti-HAV antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T-score of mineral density of lumber spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak Torque of knee flexors and extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Inflammatory marker level (matrix metalloproteinase 9)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-TEST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STAR EXCURSION TEST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 20M SPRINT TEST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of withholding or withdrawing of life-sustaining therapy
Endpoint domain: Mortality/survival
Primary endpoint: Patient Survival After Porcine Transplant
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of thrombocytopenia or indicators of consumptive coagulopathy after transplant with porcine kidney
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Development of anti-human leukocyte antigen (HLA) antibody/alloantibody sensitization after transplant with a porcine kidney
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average Daily Wearing Time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Microbiota profiles of fecal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of total daily sedentary time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported severity of Psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of tinlarebant in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of retinol-binding protein 4 (RBP4) in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glottic Opening Percentage (POGO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensorimotor integration abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical signs of Parkinson and dystonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of patient health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of agitated and aggressive behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of children prescribed an antibiotic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myeloid cell sub-population phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of alteration of the NDM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Euphoria
Endpoint domain: Adverse events/effects
Primary endpoint: Pharyngeal motor evoked potential (PMEP) amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Physical Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in laboratory Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal Calprotectin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Retrograde urine reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in corneal higher order aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iCEB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of infantile liver tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 1-year tumor recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Modification in immune blood markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to complete healing of the diseased limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to recovery of walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant change from baseline of physical examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant change from baseline of vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knowledge Level Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevalence of Birth before Arrival
Endpoint domain: Mortality/survival
Primary endpoint: Patient related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of local reactions and solicited systemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in safety chemistry blood lab values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in safety hematology blood lab values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in antibody titers after second dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to death from any-cause within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of response to therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative High Blood Pressure Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to fatigue reduction diet
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Participant-reported Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total hours of sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Modified Karolinska Sleepiness Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Fitbit tracked Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mean of mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean of gap between fracture segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean of displacement of fracture segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Dry eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with solicited systemic reactogenicity symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: regional cerebral oxygen saturation (SrO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in the frequency of moderate to severe VMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability: Oswestry disability index questionnaire (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Responder rate of improvement in glabellar lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sentinel lymph node identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in measured % Unventilated Lung
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in total hemoglobin (Δ[tHb])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Identification of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: day three good quality embryo rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frequency of target practice
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hemofilter change rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of ABN401 adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of detection of methadone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of detection of methadone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue as measured by Visual Analogue Fatigue Scale (VAFS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Variability and repeatability coefficient of [O15]H2O-PET-MPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of cognitive performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Septum Deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal Airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With AEs and SAEs, Graded by Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Serum concentration of medicinal products
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PainDETECT Questionnaire for assessing Neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Short Form-12 for Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bath Ankylosing Spondylitis Disease Activity Index (BASFI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Ankylosing Spondylitis Disease Activity Score (ASDAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Trunk Control Measurement Scale (TCMS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive Predictive Value (PPV) of 68Ga-PSMA-11 PET/CT or PET/MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants with Successful Imaging without Sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Brunnstrom Stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osteoprotegrin (OPG) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian volume in millilitres
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Follicle-stimulating hormone (FSH) hormone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change of Estradiol (E2) hormone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Quality of life using Female Sexual Function Index - FSFI questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Quality of life using The Utian Quality of life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Airflow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in narcotic requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recession measurement concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fecal secretory immunoglobulin A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Whole Blood NAD+ Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Adverse Events of Grade 3 or Higher
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Thrombocytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: VAS score evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal cardiometabolic risk index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in WOMAC score from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: percentage of consistency in simultaneous contacts in maximal intercuspal position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of DRS probe
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nurse's response time to patients in distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of actionable alarms
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Response defined by potassium levels and treatment adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sulcus bleeding index (SBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Irritable Bowel Severity Scoring System (IBS-SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Occurrence of in-hospital Major Adverse Cardiac Events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Acetabular component anteversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Handwriting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biological samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes